The current valuation score of Haleon PLC is 7.23, ranking 133 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 36.08, which is 215.98% below the recent high of 114.00 and 12.48% above the recent low of 31.58.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.